Clinical Trial Update: Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide [Phase 2]

View source ↗

Summary

Phase 2 haploidentical stem cell transplantation trial using post-transplant cyclophosphamide was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Loyola University | Conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Status: TERMINATED